Literature DB >> 8772552

Self-concept and behavior in adolescent girls with Turner syndrome: potential estrogen effects.

J L Ross1, E McCauley, D Roeltgen, L Long, H Kushner, P Feuillan, G B Cutler.   

Abstract

Data on self-concept and behavior were gathered from 31 girls with Turner syndrome (TS) followed longitudinally between the ages of 12 and 16 and from 89 normal control girls recruited from public schools and assessed cross-sectionally. The two groups of girls were similar in age and racial composition. The girls with TS were treated with estrogen replacement therapy in increasing doses between the ages of 12 and 16 (100-400 ng/kg-day ethinyl estradiol). Their self-reported self-esteem and psychological well-being (Piers-Harris Self-Concept Scale) revealed significant improvement over time for most scales as well as the total score (P < 0.001). Parents reported improvement in problem behaviors, as reflected in the Child Behavior Checklist (CBCL) scales: Behavior Total, Externalizing Behavior, Aggressive Behavior, and Social Problems Behavior scales (all P < 0.001). Analysis of covariance comparing normal controls to the TS subjects revealed that at age 12 yr, TS and normal subjects differed significantly for the School Social Competency sub-scale and the Social Problems Behavior subscale (all P < 0.001). Girls with TS resembled the normal controls on all CBCL scales by ages 14-15 yr. Thus, we found improved self-concept both by self- and parental report in estrogen-treated girls with TS followed longitudinally through adolescence. An analogous correlation with age was not seen in the cross-sectional normal control sample. These findings support positive effects of estrogen on psychological well-being in girls with TS and underscores the need to initiate estrogen replacement therapy by ages 12-14 yr in this population.

Entities:  

Mesh:

Year:  1996        PMID: 8772552     DOI: 10.1210/jcem.81.3.8772552

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Executive Functions in Children and Adolescents with Turner Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Claire Mauger; Céline Lancelot; Arnaud Roy; Régis Coutant; Nicole Cantisano; Didier Le Gall
Journal:  Neuropsychol Rev       Date:  2018-04-27       Impact factor: 7.444

2.  Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Charmian A Quigley; Xiaohai Wan; Sipi Garg; Karen Kowal; Gordon B Cutler; Judith L Ross
Journal:  J Clin Endocrinol Metab       Date:  2014-04-24       Impact factor: 5.958

3.  Growth hormone plus childhood low-dose estrogen in Turner's syndrome.

Authors:  Judith L Ross; Charmian A Quigley; Dachuang Cao; Penelope Feuillan; Karen Kowal; John J Chipman; Gordon B Cutler
Journal:  N Engl J Med       Date:  2011-03-31       Impact factor: 91.245

4.  Behavioral assessment of social anxiety in females with Turner or fragile X syndrome.

Authors:  Katarzyna Lesniak-Karpiak; Michèle M M Mazzocco; Judith L Ross
Journal:  J Autism Dev Disord       Date:  2003-02

5.  Depression in Turner Syndrome: A Systematic Review.

Authors:  Lauren A Morris; Amy C Tishelman; Jessica Kremen; Rachel A Ross
Journal:  Arch Sex Behav       Date:  2019-10-09

Review 6.  Cognitive profile of Turner syndrome.

Authors:  David Hong; Jamie Scaletta Kent; Shelli Kesler
Journal:  Dev Disabil Res Rev       Date:  2009

7.  Prepubertal ultra-low-dose estrogen therapy is associated with healthier lipid profile than conventional estrogen replacement for pubertal induction in adolescent girls with Turner syndrome: preliminary results.

Authors:  Anna Ruszala; Malgorzata Wojcik; Agata Zygmunt-Gorska; Dominika Janus; Joanna Wojtys; Jerzy B Starzyk
Journal:  J Endocrinol Invest       Date:  2017-04-10       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.